Subscribe to RSS

DOI: 10.1055/s-0045-1811174
Longitudinal assessment of natural disease progression in Brazilian children and adolescents with Charcot-Marie-Tooth disease
Funding The study was financially supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (process numbers: 2024/06190-0, 2024/13227-8, 22/10786-0 and 2017/17596-4).

Abstract
Background
Charcot-Marie-Tooth disease (CMT) is a progressive neurological disorder that typically manifests in early childhood. The natural progression of CMT in Brazilian pediatric and adolescent populations remains unknown.
Objective
To evaluate the natural disease progression in Brazilian children and adolescents with CMT using the Charcot-Marie-Tooth Pediatric Scale (CMTPedS).
Methods
A longitudinal observational study was conducted to assess disease progression over a 2-year period through 3 evaluations, spaced 1 year apart, in children and adolescents aged 5 to 18 years with a confirmed CMT diagnosis. Height, weight, body mass index (BMI), fat-free mass, and functionality (assessed via the CMTPedS) were evaluated in each of the three sessions.
Results
We included 30 participants of both sexes with a mean age of 11.1 ± 3.2 years. Significant increases in height, weight, and BMI were observed, alongside a decline in the percentage of lean body mass across evaluations. The total score on the CMTPedS increased by 4.5 points throughout 2 years, indicating disease progression, with notable deterioration in functional dexterity, pinprick and vibration sensations, and gait. Significant progression was evident within 1 year, with an average annual deterioration of 2.25 points. The subgroup with CMT type 1A (CMT1A) presented an increase of 4 points in the total score, corresponding to an average annual progression of 2 points. Unlike the overall CMT group, the CMT1 subgroup did not exhibit a decline in the pinprick sensation score.
Conclusion
Children and adolescents with CMT exhibit significant disease progression within 2 years, with measurable deterioration observed as early as 1 year. The CMTPedS is a reliable tool to monitor CMT progression in this population.
Keywords
Charcot-Marie-Tooth Disease - Functional Status - Disability Evaluation - Child - AdolescentAuthors' Contributions
Conceptualization: BAS; CFF; JC; CRJAB; WMJ; ACMS Data curation: BAS; CFF; JC; CRJAB; ACMS Formal analysis: BAS; CFF; ACMS Funding acquisition: BAS; CFF; JC; CRJAB; ACMS Investigation: BAS; CFF; JC; CRJAB, WMJ; ACMS Methodology: BAS; CFF; ACMS Project administration: BAS; CFF; ACMS Resources: BAS; CFF; JC; CRJAB; WMJ; ACMS Software: BAS; CFF; ACMS Supervision: BAS; ACMS Validation: BAS; CFF; JC; CRJAB; WMJ; ACMS Visualization: BAS; CFF; JC; CRJAB; WMJ; ACMS Writing – original draft: BAS; CFF; ACMS Writing – review & editing: BAS; CFF; JC; CRJAB; WMJ; ACMS.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Editor-in-Chief: Hélio A. G. Teive (https://orcid.org/0000-0003-2305-1073).
Associate Editor: Francisco de Assis Aquino Gondim (https://orcid.org/0000-0002-8957-5796).
Publication History
Received: 16 March 2025
Accepted: 03 June 2025
Article published online:
20 August 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bruno Alvarenga Soares, Camila Fernanda de Freitas, Juliana Cardoso, Cyntia Rogean de Jesus Alves de Baptista, Wilson Marques, Ana Claudia Mattiello-Sverzut. Longitudinal assessment of natural disease progression in Brazilian children and adolescents with Charcot-Marie-Tooth disease. Arq Neuropsiquiatr 2025; 83: s00451811174.
DOI: 10.1055/s-0045-1811174
-
References
- 1 Pareyson D, Saveri P, Pisciotta C. New developments in Charcot-Marie-Tooth neuropathy and related diseases. Curr Opin Neurol 2017; 30 (05) 471-480
- 2 Juneja M, Burns J, Saporta MA, Timmerman V. Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development. J Neurol Neurosurg Psychiatry 2019; 90 (01) 58-67
- 3 Barreto LCLS, Oliveira FS, Nunes PS, Costa IMPdF, Garcez CA, Goes GM. et al. Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review. Neuroepidemiology 2016; 46 (03) 157-165
- 4 Morena J, Gupta A, Hoyle JC. Charcot-Marie-Tooth: From Molecules to Therapy. Int J Mol Sci 2019; 20 (14) 3419
- 5 Cornett KMD, Menezes MP, Bray P, Halaki M, Shy RR, Yum SW. et al; Inherited Neuropathies Consortium. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease. JAMA Neurol 2016; 73 (06) 645-651
- 6 Murphy SM, Laura M, Fawcett K, Pandraud A, Liu Y-T, Davidson GL. et al. Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 2012; 83 (07) 706-710
- 7 Fridman V, Bundy B, Reilly MM, Pareyson D, Bacon C, Burns J. et al; Inherited Neuropathies Consortium. CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry 2015; 86 (08) 873-878
- 8 Cornett KMD, Menezes MP, Shy RR, Moroni I, Pagliano E, Pareyson D. et al; CMTPedS Study Group. Natural history of Charcot-Marie-Tooth disease during childhood. Ann Neurol 2017; 82 (03) 353-359
- 9 Karakis I, Gregas M, Darras BT, Kang PB, Jones HR. Clinical correlates of Charcot-Marie-Tooth disease in patients with pes cavus deformities. Muscle Nerve 2013; 47 (04) 488-492
- 10 Jani-Acsadi A, Ounpuu S, Pierz K, Acsadi G. Pediatric Charcot-Marie-Tooth disease. Pediatr Clin North Am 2015; 62 (03) 767-786
- 11 Burns J, Ouvrier R, Estilow T, Shy R, Laurá M, Pallant JF. et al. Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability. Ann Neurol 2012; 71 (05) 642-652
- 12 Cruz KLT, Camargos ACR, Cardoso J, Baptista CRdJAd, Ramos AD, Mattiello-Sverzut AC. et al. Translation and cross-cultural adaptation of the Charcot-Marie-Tooth disease Pediatric Scale to Brazilian Portuguese and determination of its measurement properties. Braz J Phys Ther 2021; 25 (03) 303-310
- 13 Brasil. Instituto Brasileiro de Geografia e Estatística (IBGE). Pesquisa Nacional por Amostra de Domicílios Contínua. Rio de Janeiro: IBGE, 2025. Available from: https://www.ibge.gov.br/estatisticas/sociais/saude/9171-pesquisa-nacional-por-amostra-de-domicilios-continua-mensal.html
- 14 Gomes SM, Miranda GMD, Sousa FdOS, Nascimento CNBd, Lima MLLTd, Silva VdL, Vilela MBR. Physical/functional rehabilitation in Brazil: spatiotemporal analysis of the offer in the Public Healthcare System. Cien Saude Colet 2023; 28 (02) 373-383
- 15 Cardoso J, Baptista CRdJAd, Buzzetti BP, Sartor CD, Marques Júnior W, Sacco IdCN, Mattiello-Sverzut AC. Vibration perception among children and adolescents with Charcot-Marie-tooth disease and implications for foot posture. Clin Biomech (Bristol) 2023; 110: 106114
- 16 Kelly A, Winer KK, Kalkwarf H, Oberfield SE, Lappe J, Gilsanz V, Zemel BS. Age-based reference ranges for annual height velocity in US children. J Clin Endocrinol Metab 2014; 99 (06) 2104-2112
- 17 Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51 (03) 170-179
- 18 World Health Organization (WHO). . BMI-for-age (5–19 years). Available from: https://www.who.int/tools/growth-reference-data-for-5to19-years/indicators/bmi-for-age
- 19 Donlevy GA, Cornett KMD, Garnett SP, Shy R, Estilow T, Yum SW. et al. Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth Disease. Neurology 2023; 101 (07) e717-e727
- 20 Deurenberg P, Pieters JJL, Hautvast JGAJ. The assessment of the body fat percentage by skinfold thickness measurements in childhood and young adolescence. Br J Nutr 1990; 63 (02) 293-303
- 21 World Health Organization (WHO). . WHO guidelines on physical activity and sedentary behaviour. Published online 2020. Availble from: https://www.who.int/publications/i/item/9789240015128
- 22 Sman AD, Hackett D, Fiatarone Singh M, Fornusek C, Menezes MP, Burns J. Systematic review of exercise for Charcot-Marie-Tooth disease. J Peripher Nerv Syst 2015; 20 (04) 347-362
- 23 Baptista CR, Nascimento-Elias AH, Garcia B, Testa A, Domingues PC, Martinez EZ. et al. Physical function and performance measures of children and adolescents with Charcot-Marie-Tooth disease. Physiother Theory Pract 2021; 37 (01) 73-80
- 24 Kennedy RA, Carroll K, McGinley JL. Gait in children and adolescents with Charcot-Marie-Tooth disease: a systematic review. J Peripher Nerv Syst 2016; 21 (04) 317-328
- 25 Corrado B, Ciardi G, Bargigli C. Rehabilitation Management of the Charcot-Marie-Tooth Syndrome: A Systematic Review of the Literature. Medicine (Baltimore) 2016; 95 (17) e3278